204 related articles for article (PubMed ID: 31236416)
21. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ
Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892
[No Abstract] [Full Text] [Related]
22. Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies.
Avogaro A; Barillà F; Cavalot F; Consoli A; Federici M; Mancone M; Paolillo S; Pedrinelli R; Perseghin G; Perrone Filardi P; Scicali R; Sinagra G; Spaccarotella C; Indolfi C; Purrello F
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1671-1690. PubMed ID: 33994263
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of type 2 diabetes mellitus.
DeFronzo RA
Med Clin North Am; 2004 Jul; 88(4):787-835, ix. PubMed ID: 15308380
[TBL] [Abstract][Full Text] [Related]
24. Diabetic stress: new triumphs and challenges to maintain vascular longevity.
Maiese K
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):281-4. PubMed ID: 18327989
[No Abstract] [Full Text] [Related]
25. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
Palumbo PJ
J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?
Low Wang CC; Everett BM; Burman KD; Wilson PWF
Circulation; 2019 Apr; 139(14):1741-1743. PubMed ID: 30933621
[No Abstract] [Full Text] [Related]
27. Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest?
Swislocki AL; Jialal I
Metab Syndr Relat Disord; 2016 Feb; 14(1):3-6. PubMed ID: 26677930
[TBL] [Abstract][Full Text] [Related]
28. Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects.
Shubrook JH
J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):Sii-1. PubMed ID: 21928545
[No Abstract] [Full Text] [Related]
29. Antihyperglycemic therapies and cardiovascular outcomes in patients with type 2 diabetes mellitus: State of the art and future directions.
Kato ET; Das SR; McGuire DK
Trends Cardiovasc Med; 2021 Feb; 31(2):101-108. PubMed ID: 31982285
[TBL] [Abstract][Full Text] [Related]
30. New Therapeutic Strategies for Type 2 Diabetes
Yehya A; Sadhu AR
Methodist Debakey Cardiovasc J; 2018; 14(4):281-288. PubMed ID: 30788014
[TBL] [Abstract][Full Text] [Related]
31. Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus.
Baldwin MD
J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S2-12. PubMed ID: 21813732
[TBL] [Abstract][Full Text] [Related]
32. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
[No Abstract] [Full Text] [Related]
33. [Not Available].
Steurer J
Praxis (Bern 1994); 2016 Sep; 105(20):1221-1222. PubMed ID: 27705192
[No Abstract] [Full Text] [Related]
34. Correction: glucose control and cardiovascular disease in type 2 diabetes.
Ann Intern Med; 2010 Jan; 152(1):67. PubMed ID: 20052788
[No Abstract] [Full Text] [Related]
35. A failure to communicate.
Curry A
Diabetes Forecast; 2014 Jan; 67(1):92-3. PubMed ID: 25868303
[No Abstract] [Full Text] [Related]
36. [Not Available].
Bollheimer C
Drug Res (Stuttg); 2019 Nov; 69(S 01):S29-S30. PubMed ID: 31731312
[No Abstract] [Full Text] [Related]
37. Oral treatments for type II diabetes in patients with cardiovascular disease.
Brosnan R
Cardiol Rev; 2003; 11(1):35-40. PubMed ID: 12493134
[TBL] [Abstract][Full Text] [Related]
38. Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?
Abenavoli L; Rouabhia S
Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):295-7. PubMed ID: 23639086
[No Abstract] [Full Text] [Related]
39. Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes.
Herman ME; O'Keefe JH; Bell DSH; Schwartz SS
Prog Cardiovasc Dis; 2017; 60(3):422-434. PubMed ID: 28958751
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL.
Torekov SS
Cardiovasc Res; 2018 Aug; 114(10):e70-e71. PubMed ID: 30052921
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
